股票 › SLN
赛伦斯治疗 SLN
美股市值排名 #3083
$19.73 +$0.01 (+0.05%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $19.78 +0.28%
开盘$19.75
昨收$19.72
当日区间$19.72 – $19.77
成交量958.4K
市值$1.23B
市盈率（TTM）–
股息率–
SLN 相关新闻
匹配 Silence Therapeutics 或代码 SLN 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75
- William Blair Maintains Silence Therapeutics(SLN.US) With Buy Rating
- Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating
- Silence Therapeutics Expects Offering to Close on or About Aug. 13 SLN
- Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $32
- A Quick Look at Today's Ratings for Silence Therapeutics(SLN.US), With a Forecast Between $27 to $75
- Cantor Fitzgerald Initiates Silence Therapeutics(SLN.US) With Buy Rating
- Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $25
- Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Cuts Target Price to $27 负面
- Silence Therapeutics (SLN) Receives a Buy From H.C. Wainwright
- H.C. Wainwright Reaffirms Their Buy Rating on Silence Therapeutics (SLN)
- William Blair Maintains Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $5.5
- Goldman Sachs Maintains Silence Therapeutics(SLN.US) With Sell Rating, Maintains Target Price $4
- Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)
- H.C. Wainwright Downgrades Silence Therapeutics(SLN.US) to Hold Rating, Cuts Target Price to $20 负面
暂无评论——快来第一个聊聊 SLN。